Haloti Ngata Suspended Four Games For Performance Enhancing Drugs

Ravens Pro Bowl defensive tackle Haloti Ngata has been suspended by the NFL for four games – the remainder of the regular season – for violating the league's policy on performance enhancing substances.

"I made a mistake, and I own this," Ngata said via a statement released by the team.

"I took Adderall and take full responsibility for doing this. I am deeply sorry and broken up over this. I let down my family, my teammates, Ravens fans and myself. My hope is that the Ravens make the playoffs, and I believe they can do this. And, then I can come back and help us win."

In his ninth season, Ngata was having one of his best seasons in recent years. He has 31 tackles, two sacks, two interceptions and two forced fumbles.

Ngata has gone to the Pro Bowl each of the past five seasons and is one of the Ravens' defensive leaders along with outside linebacker and close friend Terrell Suggs.

Ngata will be eligible to return to the Ravens' active roster on Monday, Dec. 29, immediately following the Ravens' final regular-season game, and is eligible to participate in all playoff games.

"This is disappointing news for the Ravens," General Manager Ozzie Newsome said. "We are disappointed with Haloti, but no more than he is with himself."

Ngata's suspension is yet another blow to the Ravens in what has been an already trying year.

Running back Ray Rice's off-field troubles led to his release. Then tight end Dennis Pitta went down for the year in Week 3. Cornerback Jimmy Smith was lost for the season in Week 8.

The Ravens will now lean more on rookie second-round pick Timmy Jernigan, who is behind Ngata on the depth chart. Jernigan has come on as of late with two sacks in the past three games. He has also been one of the team's strongest run defenders.

Nose tackle Terrence Cody, who has not been activated yet since having offseason hip surgery, could also suit up now. Defensive end DeAngelo Tyson, who has been inactive the past three games, could also help.

This article has been reproduced in a new format and may be missing content or contain faulty links. Please use the Contact Us link in our site footer to report an issue.

Related Content